Comments on "Systemic exposure of oxaliplatin and docetaxel in gastric patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy".

Authors :: de Jong LAW
van Erp NP
de Reuver PR
Source :: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2021 May; Vol. 47 (5), pp. 1216-1217. Date of Electronic Publication: 2020 Sep 19.
Publication Year :: 2021
Abstract: Competing Interests: Declaration of competing interest Dr. Nielka van Erp declares the following financial activities outside the submitted work: received grants for investigator driven studies from Astellas and Janssen-Cilag and educational grants for lectures from Sanofi, Ipsen and Bayer. The other authors declare that they have no conflicts of interest.

Subjects :: Cytoreduction Surgical Procedures
Docetaxel
Humans
Hyperthermic Intraperitoneal Chemotherapy
Oxaliplatin therapeutic use
Peritoneal Neoplasms drug therapy
Peritonitis chemically induced

Language :: English
ISSN :: 1532-2157
Volume :: 47
Issue :: 5
Database :: MEDLINE
Journal :: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Publication Type :: Editorial & Opinion
Accession number :: 32988701
Full Text :: https://doi.org/10.1016/j.ejso.2020.09.020

Full Text Access

Tools